| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 10/31/2006 | US7129072 Crystal of fibroblast growth factor receptor 1 in complex with fibroblast growth factor |
| 10/31/2006 | US7129071 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 10/31/2006 | US7129069 comprises an amino acid sequence of a catalytic module having glucoamylase activity and an amino acid sequence of a carbohydrate-binding module; producing syrup or a fermentation product from granular starch comprising subjecting the raw starch to an alpha-amylase and a hybrid enzyme having glucoamylase |
| 10/31/2006 | US7129066 Nucleotide sequences coding for the citE gene |
| 10/31/2006 | US7129059 decarbonylation of secondary amides in the presence of hydrolase enzymes, cofactors and optionally stabilizer agents, to form primary amines |
| 10/31/2006 | US7129057 Human testis specific serine/threonine kinase 3 |
| 10/31/2006 | US7129049 detecting the presence of a biomarker; presence of A nucleotides at nucleotide 102 in both alleles is indicative of the horse being predisposed to or has GSD IV |
| 10/31/2006 | US7129040 identification, on human chromosome 10, of a tumor suppressor gene. Defects in this gene are associated with the development of cancers, such as gliomas |
| 10/31/2006 | US7128904 Material containing metal ion ligand complex producing nitric oxide in contact with blood |
| 10/31/2006 | CA2243755C Streptococcal c5a peptidase vaccine |
| 10/31/2006 | CA2148482C Deblocking the common pathway of aromatic amino acid synthesis |
| 10/27/2006 | WO2005100555A2 Acethylcholinesterase(ache) variants of the n-terminus |
| 10/27/2006 | CA2562567A1 Acethylcholinesterase(ache) variants of the n-terminus |
| 10/26/2006 | WO2006113085A2 D-amino acid dehydrogenase and method of making d-amino acids |
| 10/26/2006 | WO2006112040A1 NOVEL β-GALACOTSIDE-α-2,3-SIALYLTRANSFERASE, GENE ENCODING THE SAME AND METHOD OF PRODUCING THE SAME |
| 10/26/2006 | WO2006112025A1 NOVEL β-GALACTOSIDE-α-2,3-SIALYLTRANSFERASE, GENE ENCODING THE SAME AND METHOD FOR PRODUCING THE SAME |
| 10/26/2006 | WO2006111372A2 Phytase |
| 10/26/2006 | WO2006084953A9 Novel microbial enzymes and their use |
| 10/26/2006 | WO2006084694A3 Use of the mcm8 gene for the preparation of a pharmaceutical composition |
| 10/26/2006 | WO2006079567A3 Brassica plant comprising a mutant fatty acid desaturase |
| 10/26/2006 | WO2006063058A3 Small molecule inhibitors of bacterial dam dna methyl transferases |
| 10/26/2006 | WO2006055416A3 Transgenic mouse capable of over-expressing vascular endothelial protein tyrosine phosphatase (ve-ptp) |
| 10/26/2006 | WO2006054164B1 A single step procedure for the purification and activation of tagged p38 map kinase |
| 10/26/2006 | WO2006034286A3 Isopentenyl transferase sequences and methods of use |
| 10/26/2006 | WO2006032916A3 A method for increasing seed size |
| 10/26/2006 | WO2006022882A3 Canine pancreatic lipse |
| 10/26/2006 | WO2006008660A3 Streptococcus pneumoniae enoyl- (acyl-carrier-protein) reductase (fabk) |
| 10/26/2006 | WO2005106011A3 Process for preparing dipeptidyl iv inhibitors and intermediates therefor |
| 10/26/2006 | WO2005087917A8 Enzyme and preparation method |
| 10/26/2006 | WO2005035719A3 Modified luciferase |
| 10/26/2006 | WO2004071168A3 Nucleic acids encoding anthelmintic agents and plants made therefrom |
| 10/26/2006 | WO2004031346A3 Methods and compositions concerning designed highly-specific nucleic acid binding proteins |
| 10/26/2006 | WO2002101008A3 Intracellular signaling molecules |
| 10/26/2006 | WO2002090522A3 Use of phosphorothiolate polynucleotides in ligating nucleic acids |
| 10/26/2006 | US20060242739 Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (nppase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants |
| 10/26/2006 | US20060242735 Nucleic acid fragments encoding isoflavone synthase |
| 10/26/2006 | US20060242730 Methods and compositions for tobacco plants with reduced nitrosamines |
| 10/26/2006 | US20060242722 Genetic manipulation of nonhuman animals to be used for xenotransplantation; null swine; obtaining a line of cells from a GGTA1 heterozygous swine, enriching them by treatment with agents that specifically bind alpha (1,3)-galactose epitope and deplete cells that do not, scanning for viable cells |
| 10/26/2006 | US20060241291 Purified antibody, monoclonal antibody, or polyclonal antibody that binds to DES protein of Mycobacterium tuberculosis; medical diagnosis |
| 10/26/2006 | US20060241041 Fvii or fviia gla domain variants |
| 10/26/2006 | US20060241039 reduce blood clotting activity by reducing thrombin generation; thrombotic diseases |
| 10/26/2006 | US20060240537 Isolated nucleic acid sequence encoding plant acid phosphatase |
| 10/26/2006 | US20060240535 Carbonyl reductase from lactococcus lactis |
| 10/26/2006 | US20060240534 Process for producing scyllo-inositol |
| 10/26/2006 | US20060240533 Assembly for the stabilisation of vertebral bodies of the spine |
| 10/26/2006 | US20060240532 Amplification, translation, transcription |
| 10/26/2006 | US20060240531 Processes for producing isomaltose and isomaltitol and use thereof |
| 10/26/2006 | US20060240530 cDNA of a severe acute respiratory syndrome (SARS) coronavirus, recombinant SARS coronavirus vectors, and SARS coronavirus replicon particles |
| 10/26/2006 | US20060240528 Polyketides and their synthesis |
| 10/26/2006 | US20060240526 Amino acid substitution in position 36; brain bleeding, hemorrhage, trauma or injury; genetic engineering and expression; biodrugs, anticoagulants |
| 10/26/2006 | US20060240525 Factor VII or VIIa - Like Molecules |
| 10/26/2006 | US20060240524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 10/26/2006 | US20060240522 Process for bacterial production of polypeptides |
| 10/26/2006 | US20060240521 DNA sequences for regulating transcription |
| 10/26/2006 | US20060240514 Fermentation of product for growth medium with reduced levels of animal meat or dairy product |
| 10/26/2006 | US20060240509 Myrothecium sp transformation and expression system |
| 10/26/2006 | US20060240508 By culturing yeast organisms that have an increased Delta 8-, Delta 7-, Delta 24-, Delta 5-isomerase and HMG-CoA-reductase activity |
| 10/26/2006 | US20060240502 GTP cyclohydrolase II as a target for fungicides |
| 10/26/2006 | US20060240501 Removing fructosyl group from a fructosylated peptide or protein by reacting with an aqueous Pyrus pyrifolia, Vitis vinifera, or Daucus carota extract containing an enzyme that removes the fructose without removing an amino acid residue; detecting reaction products |
| 10/26/2006 | US20060240476 Thrombotic thrombocytopenic purpura (TTP); epitope recognized by an antibody (anti-ADAMTS-13 antibody) against a cleaving protease ( ADAMTS-13) specific to von Willebrand factor |
| 10/26/2006 | US20060240470 Gene causative of Rothmund-Thomson syndrome and gene product |
| 10/26/2006 | US20060240468 Method of reverse transcription |
| 10/26/2006 | US20060240464 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 10/26/2006 | US20060240459 ClCKb mutation as a diagnostic and therapeutical target |
| 10/26/2006 | US20060240440 primer amplification |
| 10/26/2006 | US20060240439 Modified polymerases for improved incorporation of nucleotide analogues |
| 10/26/2006 | US20060240433 Facls as modifiers of the rb pathway and methods of use |
| 10/26/2006 | US20060240414 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 10/26/2006 | US20060240406 Method for the detection of proteolytic enzymes |
| 10/26/2006 | US20060240114 Drug for treating hemophilia and method of treating hemophilia using the same |
| 10/26/2006 | US20060240053 cosmetic or pharmaceutical composition comprising, in a physiologically acceptable medium, at least one purified natural or synthetic polypeptide wherein the peptide sequence is represented wholly or partly by at least one sequence |
| 10/26/2006 | US20060240036 I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis |
| 10/26/2006 | US20060240020 Inhibition of complement activation |
| 10/26/2006 | US20060239994 Obtained by cloning of cDNA encoding novel human and mouse serine proteases |
| 10/26/2006 | US20060239993 Containing a mutant angiotensin-converting enzyme that releases glycosylphosphatidylinositol-anchored protein from cell surfaces; for treating a prion-related disease, a bacterial infectious disease or male infertility due to sperm-egg binding insufficiency |
| 10/26/2006 | US20060239991 polypeptide has the biological activity of methionyl tRNA synthetase; for the protection against bacterial infections |
| 10/26/2006 | US20060239990 Protein Arginine N-Methyltransferase 2 (PRMT-2) |
| 10/26/2006 | US20060239989 Stable and which can be obtained in a large quantity, with a high level of purity and of activity |
| 10/26/2006 | US20060239967 Oncolytic virus replicating selectively in tumor cells |
| 10/26/2006 | US20060239960 Polymer-based compositions and conjugates of antimicrobial agents |
| 10/26/2006 | US20060237025 Method of reducing the harmful effects of orally or transdermally delivered nicotine |
| 10/26/2006 | DE4244539B4 Duale Inhibitoren der No-Synthese und Cyclooxygenase, Verfahren zu ihrer Herstellung und therapeutische Präparate, die sie enthalten Dual inhibitors of NO synthesis and cyclooxygenase, processes for their preparation and therapeutic compositions containing them |
| 10/26/2006 | CA2608410A1 A novel .beta.-galactoside-.alpha.2, 3-sialyltransferase, a gene encoding thereof, and a method for producing thereof |
| 10/26/2006 | CA2606136A1 Method and composition to evaluate cytochrome p450 2d6 isoenzyme activity using a breath test |
| 10/25/2006 | EP1715057A2 Methods of modifying carbohydrate moieties |
| 10/25/2006 | EP1715055A2 Process for the production of L-amino acids using improved Enterobacteriaceae strains |
| 10/25/2006 | EP1715049A1 Method of detecting and quantifying human P450 molecular species and probe and kit for this method |
| 10/25/2006 | EP1715047A2 Recombinant mutants for inducing specific immune responses |
| 10/25/2006 | EP1715036A1 Crystal structure of an Aurora-B/INCENP complex |
| 10/25/2006 | EP1715035A2 Synthetic polynucleotides encoding lysyl oxidase |
| 10/25/2006 | EP1714974A2 HIV-1-and HIV-2-peptides for inhibition of membranes fusion-associated events, including HIV transmission |
| 10/25/2006 | EP1714543A2 Plants having mutant sequences that confer altered fatty acid profiles |
| 10/25/2006 | EP1713928A2 Diagnostics and therapeutics for diseases associated with putative cysteine protease 1 (prsc1) |
| 10/25/2006 | EP1713923A1 Enzymatic asymmetric decarboxylation of disubstituted malonic acids |
| 10/25/2006 | EP1713921A2 Expression of plasminogen and microplasminogen in duckweed |
| 10/25/2006 | EP1713920A1 A method for regulating plant growth |
| 10/25/2006 | EP1713919A2 Protease variants |
| 10/25/2006 | EP1713908A2 Recombinant dna for gene suppression |
| 10/25/2006 | EP1713907A2 Hybrid proteins of active-site serine beta-lactamase. |
| 10/25/2006 | EP1713906A2 Coagulation factor vii/viia variants lacking functional lipid membrane binding domain |